An Examination of the Ethical and Legal Limits in Implementing “Traceback Testing” for Deceased Patients

, , , , , , , , &
Journal of Law, Medicine and Ethics 50 (4):818-832 (2022)
  Copy   BIBTEX

Abstract

This paper examines the legal and ethical aspects of traceback testing, a process in which patients who have been previously diagnosed with ovarian cancer are identified and offered genetic testing so that their family members can be informed of their genetic risk and can also choose to undergo testing. Specifically, this analysis examines the ethical and legal limits in implementing traceback testing in cases when the patient is deceased and can no longer consent to genetic testing.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2023.23

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,853

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Attitudes of Rhode Island primary care physicians toward the use of genetic testing for breast cancer.Frances M. Alexakos - unknown
Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.Pål Møller & Eivind Hovig - 2018 - Medicine, Health Care and Philosophy 21 (2):239-242.
Genetic Testing after Breast Cancer Diagnosis: Implications for Physician-Patient Communications.Nancy Berlinger - 2004 - Cambridge Quarterly of Healthcare Ethics 13 (4):417-419.
Genetic testing for breast cancer risk, from BRCA1/2 to a seven gene panel: an ethical analysis.Erik Gustavsson, Giovanni Galvis & Niklas Juth - 2020 - BMC Medical Ethics 21 (1):1-8.
Risks and Benefits, Testing and Screening, Cancer, Genes and Dollars.Eric Kodish - 1997 - Journal of Law, Medicine and Ethics 25 (4):252-255.
Localizing the Global: Testing for Hereditary Risks of Breast Cancer.Jean Paul Gaudillière & Ilana Löwy - 2008 - Science, Technology, and Human Values 33 (3):299-325.
Cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer.Nikki Breheny, Elizabeth Geelhoed, Jack Goldblatt & Peter O'Leary - 2005 - Genomics, Society and Policy 1 (2):1-13.
Collective Fear, Individualized Risk: the social and cultural context of genetic testing for breast cancer.N. Press, J. R. Fishman & B. A. Koenig - 2000 - Nursing Ethics 7 (3):237-249.
Much more than a gene: hereditary breast and ovarian cancer, reproductive choices and family life. [REVIEW]Catherine Dekeuwer & Simone Bateman - 2013 - Medicine, Health Care and Philosophy 16 (2):231-244.
Cultural Basis for Differences Between US and French Clinical Recommendations for Women at Increased Risk of Breast and Ovarian Cancer.Francois Eisinger, G. Geller, W. Burke & N. A. Holtzman - 1999 - The Lancet 353:919-920.
Collective Fear, Individualized Risk: the social and cultural context of genetic testing forbreast cancer.N. Press, J. R. Fishman & B. A. Koenig - 2000 - Nursing Ethics 7 (3):237-249.
Ethics and Breast Cancer.Amtul R. Carmichael & Kerstin Sandelin - 2019 - In Alberto R. Ferreres (ed.), Surgical Ethics: Principles and Practice. Springer Verlag. pp. 257-264.
Direct to confusion: Lessons learned from marketing brca testing.Ellen Matloff & Arthur Caplan - 2008 - American Journal of Bioethics 8 (6):5 – 8.
Genetic Testing for Susceptibility to Breast and Ovarian Cancer: A Case Study of Clinical Decision-Making in Medical Genetics.Andrea Edith Glassberg - 1997 - Dissertation, University of Washington
Ethical Issues Related To BRCA Gene Testing in Orthodox Jewish Women.Pnina Mor & Kathleen Oberle - 2008 - Nursing Ethics 15 (4):512-522.

Analytics

Added to PP
2023-03-10

Downloads
71 (#230,886)

6 months
70 (#68,528)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references